Investigational Nasal Aerosol in Children with Perennial Allergic Rhinitis

Study Title

Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Female, Maleergic Rhinitis (PAR)

Teva Identifier

BDP-AR-306

ClinicalTrials.gov Identifier

NCT01783548

Study Status

Completed

Trial Condition(s)

Female, Maleergic Rhinitis

Interventions

Drug: BDP Nasal Aerosol | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

4 Years to 11 Years

Trial Duration

01/01/2013 - 10/01/2013

Phase

Phase 3

Study Type

Interventional